Microbial therapeutics: New opportunities for drug delivery

Microbial therapeutics: New opportunities for drug delivery

With >40 clinical trials underway, we are nearing the first FDA-approved live microbial therapeutic. Here, Giovanni Traverso, MIT and Harvard Medical School Assistant Professor, and colleagues Miguel Jimenez and Institute Professor Robert Langer from MIT discuss the significant challenges of admi...

Full description

Bibliographic Details
Main Authors: Jimenez, Miguel (Author), Langer, Robert S (Author), Traverso, Carlo Giovanni (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Rockefeller University Press, 2020-06-29T20:34:21Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items